- Home
- OPHC vs NEPH Comparison
OPHC vs NEPH Comparison
Compare OPHC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPHC
- NEPH
- Stock Information
- Founded
- OPHC 2000
- NEPH 1997
- Country
- OPHC United States
- NEPH United States
- Employees
- OPHC N/A
- NEPH N/A
- Industry
- OPHC Major Banks
- NEPH Medical/Dental Instruments
- Sector
- OPHC Finance
- NEPH Health Care
- Exchange
- OPHC Nasdaq
- NEPH Nasdaq
- Market Cap
- OPHC 51.8M
- NEPH 45.3M
- IPO Year
- OPHC N/A
- NEPH 2004
- Fundamental
- Price
- OPHC $4.13
- NEPH $4.08
- Analyst Decision
- OPHC
- NEPH Strong Buy
- Analyst Count
- OPHC 0
- NEPH 2
- Target Price
- OPHC N/A
- NEPH $5.50
- AVG Volume (30 Days)
- OPHC 10.3K
- NEPH 59.5K
- Earning Date
- OPHC 11-07-2025
- NEPH 11-06-2025
- Dividend Yield
- OPHC N/A
- NEPH N/A
- EPS Growth
- OPHC 6.01
- NEPH N/A
- EPS
- OPHC 1.28
- NEPH 0.12
- Revenue
- OPHC $41,269,000.00
- NEPH $16,684,000.00
- Revenue This Year
- OPHC N/A
- NEPH $24.38
- Revenue Next Year
- OPHC N/A
- NEPH $10.16
- P/E Ratio
- OPHC $3.22
- NEPH $35.83
- Revenue Growth
- OPHC 36.79
- NEPH 21.16
- 52 Week Low
- OPHC $3.53
- NEPH $1.36
- 52 Week High
- OPHC $5.90
- NEPH $5.00
- Technical
- Relative Strength Index (RSI)
- OPHC 36.64
- NEPH 50.11
- Support Level
- OPHC $4.21
- NEPH $3.62
- Resistance Level
- OPHC $4.30
- NEPH $4.94
- Average True Range (ATR)
- OPHC 0.05
- NEPH 0.41
- MACD
- OPHC -0.01
- NEPH -0.01
- Stochastic Oscillator
- OPHC 12.50
- NEPH 34.85
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.
About NEPH Nephros Inc.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.